Hutch News
Dr. M. Elizabeth ‘Betz’ Halloran receives Nathan Mantel Lifetime Achievement Award
Biostatistician honored for her landmark contributions to statistical methods for infectious disease epidemiology
First licensed dengue vaccine withstands rainy season
From the Vaccine and Infectious Disease Division
New partnership seeks to increase access to lifesaving stem-cell transplants
Celebrating faculty and staff achievements
To protect, or to enhance? That is the question for Dengue virus antibodies
From Dr. Halloran, Vaccine and Infectious Disease Division
Reconstructing Zika’s travels in the Americas
From the Vaccine and Infectious Disease Division and the Center for Inference and Dynamics of Infectious Diseases
Genomic sequencing offers new clues to Zika's spread from Brazil to the Caribbean to Miami
Genomic sequencing offers new clues to the virus’ spread from Brazil to the Caribbean to Miami
Good News: Dr. Betz Halloran wins award in Rome; Hutch nominated for SLU nonprofit of the year; Obliteride amassed $2.4M in donations
Celebrating faculty and staff achievements
Tracking the rise and fall of Ebola in Sierra Leone
Study pins numbers on outbreak’s devastation, interventions that worked
Zika virus: 6 key things we don’t yet know
From lack of data to inconclusive blood tests to the unique challenges of pregnancy, experts weigh in on the knowledge gaps in this emerging infection
Ebola lessons applied to vaccine clinical trials
3 proposals for ‘thinking outside the box’ in public health emergencies
A warning heeded yields good news on Ebola
Disease modeling shows that treatment centers, safe burials are containing outbreak in Liberia
MIDAS touch: New Fred Hutch center to play key role in global disease response
Top award grants $12.5 million over five years to model and track pathogens from polio to Ebola
Fred Hutchinson Cancer Research Center designated MIDAS Center of Excellence
Designation puts Fred Hutch on cutting edge of U.S. analysis and response to infectious disease outbreaks around the globe - Center includes researchers from seven other academic sites across the country
Ebola cases could top 10,000 by month’s end, Fred Hutch researchers say
Disease modeling shows virus is spreading ‘without any end in sight’
‘It packs a punch’: High-dose flu vaccine cuts illness in older adults
Shot contains 4 times as much antigen, boosts antibodies and protects better, large study finds
Oral vaccine could have halved Haiti’s cholera epidemic
VIDD study shows need for comprehensive global action plan, strategy to reduce cholera-related mortality in developing countries
Brent and Eisenman named AAAS fellows
Basic scientists honored for outstanding contributions in biochemistry, transcription, genomics and systems biology, and pathbreaking studies in the field of oncogenes
Halloran named AAAS Fellow
VIDI disease modeler honored for her infectious-disease expertise
Positive projections for combating TB
Halloran and colleagues report tuberculosis vaccines, drugs and diagnostics under development could reduce incidence of the disease between 13 percent and 71 percent